Skip to main content
Family Medicine
ALL Specialities
ALL Specialities
/
Family Medicine
CME
COVID-19 Updates
The Journal of Family Practice
Current Issue
Past Issues
Author Guidelines
Specialties
Addiction Medicine
Cardiology
Dermatology
Diabetes
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pain
Pediatrics
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
For Residents
Residents' Rapid Review
Multimedia
Audio
All Podcasts
Practice Alert Podcast
Video
3-in-3
Watch & Learn
Conference Coverage
Expert: Don’t discourage pregnancy in MS patients; manage it
Publish date:
June 2, 2015
EXPERT ANALYSIS AT THE CMSC ANNUAL MEETING
dbrunk@frontlinemedcom.com
On Twitter
@dougbrunk
Pages
« first
1
2
3
Recommended Reading
Switch to oral fingolimod produces better MS outcomes
MDedge Family Medicine
‘No evidence of disease activity’ has potential as a useful outcome in MS
MDedge Family Medicine
New patient registry aims to become ‘Framingham’ of MS
MDedge Family Medicine
Interferon beta, glatiramer acetate prove effective for relapsing MS
MDedge Family Medicine
FDA approves first generic version of MS drug glatiramer acetate
MDedge Family Medicine
DECIDE: Daclizumab cuts MS relapse rate by 45%
MDedge Family Medicine
Peginterferon beta-1a MS data show positive early and long-term results
MDedge Family Medicine
AAN: Study supports safety of fingolimod for MS
MDedge Family Medicine
Botox treatments improve urinary incontinence in neurogenic bladder dysfunction
MDedge Family Medicine
VIDEO: Cannabis further compromises cognitive function in some MS patients
MDedge Family Medicine
Neurology
Women's Health
All Specialties
